APA (7th ed.) Citation

AE, E., AP, H., WJ, R., PR, L., AA, S., JL, A., . . . Wyse, D. G. (1993). Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA: Journal of the American Medical Association, 270(20), 2451. https://doi.org/10.1001/jama.270.20.2451

Chicago Style (17th ed.) Citation

AE, Epstein, et al. "Mortality Following Ventricular Arrhythmia Suppression by Encainide, Flecainide, and Moricizine After Myocardial Infarction. The Original Design Concept of the Cardiac Arrhythmia Suppression Trial (CAST)." JAMA: Journal of the American Medical Association 270, no. 20 (1993): 2451. https://doi.org/10.1001/jama.270.20.2451.

MLA (9th ed.) Citation

AE, Epstein, et al. "Mortality Following Ventricular Arrhythmia Suppression by Encainide, Flecainide, and Moricizine After Myocardial Infarction. The Original Design Concept of the Cardiac Arrhythmia Suppression Trial (CAST)." JAMA: Journal of the American Medical Association, vol. 270, no. 20, 1993, p. 2451, https://doi.org/10.1001/jama.270.20.2451.